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S U M M A R Y
Objectives: This study was conducted to determine the prevalence of diabetes mellitus among
tuberculosis (TB) patients attending three TB clinics in Guyana.
Methods: A cross-sectional study was conducted among TB patients attending TB clinics in three regions
in Guyana. A structured questionnaire was used to collect demographic, clinical, and risk factor data.
Random blood sugar testing was done using the OneTouch UltraSmart glucometer (LifeScan, Inc., 2002).
Results: One hundred TB patients were recruited; 90 had pulmonary TB and 10 had extrapulmonary
disease. Fourteen patients were classiﬁed as diabetic: 12 had been previously diagnosed as diabetic by a
physician and two had abnormally high random blood sugar at the time of enrolment. Of the 12 known
diabetics, seven had been diagnosed before TB was discovered, three were identiﬁed at the time TB was
diagnosed, and two after TB was diagnosed. All 14 diabetic patients presented with pulmonary TB. Thirty-
one patients were HIV-positive and 28 of these had pulmonary TB, whereas three had extrapulmonary TB.
None of the diabetics were infected with HIV. TB-diabetic patients tended to be older than non-diabetics
(median age 44 vs. 36.5 years), were more likely to have been incarcerated at the time of TB diagnosis
than non-diabetics (p = 0.06), and were more likely to have an elevated (random) blood sugar level
(p = 0.02). Clinically, diabetes did not inﬂuence the presentation of TB.
Conclusions: This study clearly highlights that diabetes and HIV are frequent in Guyanese TB patients.
Routine screening of TB patients for diabetes and diabetic patients for TB should be speedily
implemented. The National TB Programme should work closely with the diabetes clinics so that TB
patients who are diabetics are optimally managed.
 2011 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
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jou r nal h o mep ag e: w ww .e lsev ier . co m / loc ate / i j id1. Introduction
The World Health Organization (WHO) estimated that there
were approximately 8.8 million new tuberculosis (TB) cases and
1.6 million deaths worldwide in 2005. Almost 2 billion people are
estimated to be infected with the TB bacilli.1 The lifetime risk of
progression to active TB in healthy persons is estimated to be 5–
10%.2 In persons with weakened immune systems, the annual and
lifetime risks of progression of latent TB to active disease are
considerably higher.3 Conditions that weaken the immune
response, such as HIV infection, the use of corticosteroids or
chemotherapy for cancers, and other chronic disease such as
diabetes mellitus, have all been linked to the progression of latent
TB to active disease.4,5* Corresponding author. Tel.: +1 613 737 8899 ext. 74748; fax: +1 613 737 8324.
E-mail address: kramotar@ottawahospital.on.ca (K. Ramotar).
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doi:10.1016/j.ijid.2011.07.006Many studies have examined the relationship between diabetes
and TB. Diabetics, especially those with type 2 diabetes mellitus,
have been shown to be at increased risk of TB infection in several
settings.6,7 In Canada, type 2 diabetes mellitus was an important
independent predictor for TB in Saskatchewan women aged 20–
59.7 Studies have demonstrated that prevalence rates of diabetes in
TB patients can vary from as low as 3% in Conakry to as high as 29%
in Mexico.8–10 In fact, in some studies, TB–diabetes co-morbidities
have been shown to be much more frequent than TB–HIV co-
infections.10,11 While diabetes clearly increases TB risk, the exact
mechanism by which this occurs is poorly understood. The high
prevalence of diabetes in TB patients has led to some suggestions of
the likelihood that active TB may be a risk factor for diabetes, if not
playing a direct role in the pathogenesis of this disease.12
Guyana is at a point of epidemiological transition with high
incidences of infectious diseases such as malaria, tuberculosis, and
HIV, and a high burden of chronic diseases such as diabetes and
cardiovascular diseases (Guyana Ministry of Health report). The
burden of TB and diabetes overlap geographically in the moreses. Published by Elsevier Ltd. All rights reserved.
Table 1
Demographic characteristics of TB patients (n = 100)
All TB patients
(n = 100)
Patients with
TB and DM
(n = 14)
Patients with
TB only
(n = 86)
Female 44% 35.7% 45.3%
Male 56% 64.3% 54.7%
Age group, years
0–14 6% 7.1% 5.8%
15–24 14% 7.1% 15.1%
25–34 23% 7.1% 25.6%
35–55 28% 35.7% 26.7%
45–54 20% 21.5% 19.8%
55 and older 9% 21.5% 7.0%
Ethnicity
African 52% 35.7% 54.7%
Indian 32% 42.9% 30.2%
Mixed 10% 7.1% 10.5%
Amerindian 6% 14.3% 4.7%
TB, tuberculosis; DM, diabetes mellitus.
Table 2
Clinical features of pulmonary TB patients (n = 90)
All patients with
pulmonary TB
(n = 90)
Patients with
pulmonary TB and
DM (n = 14)
Patients with
pulmonary TB
only (n = 76)
Cough 82.2% 85.7% 81.6%
Weight loss 80% 78.6% 80.3%
Night sweats 72.2% 71.4% 72.4%
Fever 64.4% 78.6% 61.8%
Chest pain 61.1% 57.1% 61.8%
Bloody sputum 36.7% 42.9% 35.5%
AFB sputum smear results
Negative 54.4% 57.1% 54.0%
Positive 35.6% 28.6% 36.8%
Unknown 10% 14.3% 9.2%
TB, tuberculosis; DM, diabetes mellitus; AFB, acid-fast bacillus.
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the high incidence countries for TB in the Western Hemisphere
with an estimated incidence of TB of 185/100 000 population
(WHO 2004 TB country proﬁle for Guyana). While Guyana’s 2005
TB treatment guidelines clearly identify diabetes as a risk factor for
TB in Guyana, the true relationship between TB and diabetes has
never been established among Guyanese TB patients.
The objectives of this study were: (1) to determine the
prevalence of diabetes among TB patients attending chest clinics
in Georgetown, Linden, and New Amsterdam (the three main cities
in Guyana), and (2) to describe the epidemiology of TB–diabetes
co-morbidity and the clinical presentation of TB in diabetics.
2. Methods
This study was conducted during the months of May and June
2006 at three of the largest TB clinics located in Georgetown, New
Amsterdam, and Linden. A cross-sectional design was utilized. A
detailed questionnaire was used to collect socio-demographic,
clinical, and risk factor data for both TB and diabetes. Clinics were
visited by investigators on scheduled clinic days and all TB patients
in attendance during these visits were eligible for participation in
the study. Patients were informed of the nature of the study and
verbal consent was solicited prior to patient recruitment. For
minors, consent was sought from parents. University of Guyana
medical students who were part of the investigator group used the
study questionnaire to collect patient data, and a random blood
sugar test was performed on enrolled patients (by clinic personnel)
on completion of the interview. Random blood sugar testing was
done using the OneTouch UltraSmart glucometer (2002; LifeScan,
Inc., Milpitas, CA, USA). Patient charts were reviewed to verify
particulars and to conﬁrm the results of laboratory tests. Patients
with abnormal random blood sugar readings were referred to the
clinic’s attending physician for further evaluation.
Diabetics were deﬁned as persons who were either diagnosed
by a physician or who had an abnormally high random blood sugar
(>200 mg/dl) at the time of study enrolment. TB patients were
those with a clinical, radiological, or microbiological diagnosis of
TB and who were placed on anti-TB therapy according to national
guidelines.
Approval to conduct the investigation was obtained from the
National TB Programme (NTP) of Guyana. Study participation was
voluntary with informed consent. No patient identifying data were
recorded on questionnaires. Patient charts were reviewed at the
clinic and only pertinent data were extracted.
An electronic database was created in EpiInfo version 3.2.2
(Centers for Disease Control and Prevention, Atlanta, GA, USA) and
was used for data analysis. The socio-demographic characteristics
of study participants were described using univariate analyses. The
frequency of common risk factors and clinical manifestations were
examined. Bivariate analyses compared the socio-demographics,
risk factors, and clinical presentations of TB patients who were
diabetics with TB non-diabetics. The Chi-square test and Student’s
t-test were used to compare qualitative and numerical variables,
respectively.
3. Results
One hundred TB patients were recruited: 70 from Georgetown,
24 from New Amsterdam, and six from Linden TB clinics. Ninety
patients had pulmonary TB and 10 had extrapulmonary disease.
Fourteen of the 100 (14%) patients were classiﬁed as diabetic.
Twelve of these had been previously diagnosed by a physician and
two had abnormally high random blood sugar at the time of
enrolment. Of the 12 known diabetics, seven had been diagnosed
before their TB was discovered, three were diagnosed at the timeTB was diagnosed, and two after TB was diagnosed. Seven of the 12
known diabetics were being managed with oral anti-diabetic drugs
(type 2 diabetes). All diabetics presented with pulmonary TB.
Thirty-one (31%) patients were HIV-positive; 28 of these had
pulmonary TB and three had extrapulmonary TB. However, none of
the diabetics were infected with HIV.
The median age of the study patients was 38 years (range 3–71
years) and 56% were males. The majority of patients (84%) were of
African and East Indian descent (Table 1). Forty-four (44%) TB
patients were unemployed and 15% were homeless.
TB-diabetic patients tended to be older than non-diabetics
(median age 44 vs. 36.5 years). Otherwise, both groups were
similar demographically.
The clinical presentation of pulmonary TB in the 90 patients
was typical, with most reporting cough of greater than 2 weeks
duration (82.2%), weight loss (80%), night sweats (72.2%), and fever
(64.4%) (Table 2). In this study most patients (54.4%) were acid-fast
bacillus (AFB) sputum smear-negative, but in 10% of the cases there
was no record that sputum smear microscopy had been done.
The clinical presentation of pulmonary TB among diabetics was
compared to that of TB patients who were not diabetics (Table 2).
Diabetes did not signiﬁcantly impact on the clinical manifestations
of TB. Likewise there was no signiﬁcant difference for AFB sputum
smear microscopy results between diabetics and non-diabetics.
Symptoms suggestive of diabetes were not appreciably differ-
ent between pulmonary TB patients who were diabetics and those
who were non-diabetics (Table 3), with the exception of polyuria
(Table 3). However, the mean random blood sugar of diabetics was
higher than that of non-diabetics (243.1 mg/dl vs. 97.8 mg/dl;
p = 0.02). In addition, diabetics with pulmonary TB were more
Table 3
Clinical features and risk factors for diabetic and non-diabetic pulmonary TB
patients (n = 90)
All TB patients
with pulmonary
TB (n = 90)
Patients with
pulmonary TB
and DM (n = 14)
Patients with
Pulmonary TB
only (n = 76)
Polyuria 45.6% 57.1% 43.4%
Excessive thirst 42.2% 50% 40.8%
Hunger 5.6% 14.3% 3.9%
Family history
of diabetes
44.4% 78.6% 38.2%a
Mean random blood
sugar, mg/dl
– 243.1 97.8a
TB, tuberculosis; DM, diabetes mellitus.
a Chi-square p-value 0.02; p-value t-test < 0.001.
Table 4
Behavioral and other risk factors for TB patients (n = 100)
All TB patients
(n = 100)
Patients with
TB and DM
(n = 14)
Patients with
TB only
(n = 86)
Previous abnormal CXR 57% 64.3% 55.8%
Alcohol use 44% 50% 43.0%
Unemployment 44% 35.7% 45.3%
Exposure to an
infectious case
43% 35.7% 44.2%
Non-injecting drug use 19% 7.1% 20.9%
Imprisonment at time
of TB diagnosis
18% 35.7% 15.1%a
Homelessness 15% 14.3% 15.1%
Steroid use 11% 14.3% 10.5%
TB, tuberculosis; DM, diabetes mellitus; CXR, chest X-ray.
a p = 0.06.
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pulmonary TB (78.6% vs. 38.2%; Chi-square p = 0.02).
TB patients in this study reported high levels of alcohol use
(44%), unemployment (44%), non-injecting drug use (19%),
homelessness (15%), and imprisonment at the time of their TB
diagnosis (18%) (Table 4). TB-diabetics in this study were more
likely to have been imprisoned at the time of their TB diagnosis
than non-diabetics (35.7% vs. 15.1%, Chi-square p = 0.06).
4. Discussion
In this study of 100 TB patients, 14% were diabetic. Factors
associated with diabetes in TB patients were age, history of being
incarcerated at the time of TB diagnosis, and a family history of
diabetes. TB-diabetics were also more likely to present with an
elevated random blood sugar than non-diabetics.
In this study, the prevalence of diabetes in TB patients is similar
to that reported from Indonesia, but much lower than that found in
Mexico.6,9–11 While the prevalence of diabetes in Guyana is
unknown, these differences may reﬂect differences in prevalence
of diabetes in the general population of these countries. Previous
studies have shown no association between TB–diabetes co-
morbidity and demographic factors such as gender, sex, and
ethnicity.13 Older age, however, has consistently been linked to an
increased risk of diabetes in TB patients.8,11,13 Likewise a family
history of diabetes has also been shown to be an important
predictor of diabetes in TB patients.8
In this study, there was no noticeable impact of diabetes on the
clinical presentation of pulmonary TB, including the frequency of
sputum smear-positive TB. The clinical impact of diabetes on
pulmonary TB is uncertain. Some studies have reported no clinical,
radiological, or bacteriological impact of diabetes on TB,8,13
whereas others have described higher frequencies of certainclinical symptoms and lower lung ﬁeld lesions, cavities, and AFB
smear positivity in TB–diabetes co-morbid patients.14,15 Symp-
toms suggestive of diabetes with the exception of polyuria were
not more common in diabetics than non-diabetics. The majority of
the TB diabetics in this study were receiving treatment for
diabetes, which may have inﬂuenced the frequency of diabetes
symptoms.
In Guyana the frequency of diabetes is unknown and so there
are no population-based prevalence data available against which
the prevalence of diabetes encountered in this study could be
compared. Nevertheless, the high burden of TB–diabetes co-
morbidity clearly points to the need for routine screening of TB
patients for this condition. The use of point-of-care testing for
diabetes at TB chest clinics is feasible and should be encouraged, as
this is not currently routinely done in Guyana. TB clinicians and
nurses should demonstrate a particularly high index of suspicion
for diabetes, especially in patients aged 40 years and older and
those with a family history of diabetes. Given these associations
and the inﬂuence of diabetes on the progression of latent TB to
active TB, a case can be made for the institution of routine
screening for TB among diabetics and the provision of preventive
therapy to diabetics who have latent TB. Being imprisoned at the
time of TB diagnosis was linked to diabetes, probably indicating the
acquisition of infection during the period of incarceration.
Finally, TB patients in this sample were from the socially
deprived sections of the population with a high prevalence of
unemployment, homelessness, and history of being incarcerated.
Likewise lifestyle factors such as alcohol use, cigarette smoking,
and illicit drug use were frequent among TB patients. Anecdotal
reports suggest that these types of patient are more difﬁcult to
manage and less likely to adhere to therapy. It is incumbent on the
NTP of Guyana to develop appropriate strategies for getting
treatment to this population.
In terms of limitations, this study was completed as part of the
requirements for the University of Guyana’s Bachelor of Medicine
degree program (MBBS). Only a limited period of time was allotted
to the data collection, analysis, and report writing; as such it was
not possible to interview all the patients who were on treatment at
the three clinics. Likewise the use of a random blood sugar instead
of a fasting sugar may have resulted in a misclassiﬁcation of two of
the patients as diabetic. This study relied on patient recall of
presenting symptoms and may have been affected by recall bias.
In conclusion, this study clearly highlights that diabetes is
frequent in TB patients. Consequently routine screening of TB
patients for diabetes should be speedily implemented. The use of
adequately calibrated glucometers to perform random blood sugar
tests at chest clinics is feasible and is recommended. Likewise
routine screening of diabetics for TB should be encouraged, and
isoniazid prophylaxis should be considered for diabetics with a
latent infection. The NTP must work closely with the diabetes
clinics so that TB-diabetics are optimally managed.
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